Scg

Developer of immunotherapies for pathogenic infections and cancers

placeSingapore, Singapore, Singapore calendar_todayFounded 2017 groups12 employees language scgcell.com

Registered entities

Social engagement

Social engagement: 2.1K social following, 2 posts in the last 12 months — above the industry median.

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital240%
Other / undisclosed360%

Recent activity

8 Jul 2025
Milestone
regulatory
Coming soon